2023 Form 5500 filing — Teva Pharmaceuticals Retirement Savings Plan (Puerto Rico)
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240925122310NAL0005442963001) for Teva Pharmaceuticals Retirement Savings Plan (Puerto Rico), reported by Teva Pharmaceuticals under EIN 22-1734359 and plan number 002. It reports 68 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).
Form 5500 2 · 2023
Filing snapshot
Net assets (EOY)$6MReported net assets$5,968,354
Participants68
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
- EFAST2 acknowledgement
- 20240925122310NAL0005442963001
- Plan sponsor
- Teva Pharmaceuticals
- EIN
- 22-1734359
- Plan number
- 002
- Location
- Parsippany, NJ
- Received date
- not reported in the loaded dataset
Schedule I · 2023
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
Reported balance (end of year)$6M total assets
Net assets$6MLiabilities—
Full reported line items
- Total assets (EOY)
- $5,968,354
- Net assets (EOY)
- $5,968,354
- Total income / additions
- $750,470
- Benefits paid
- $385,724
- Total expenses
- $395,820
- Net increase / (decrease)
- $354,650